The firm shows a Beta (market volatility) of -3.87, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Celularity are expected to decrease by larger amounts. On the other hand, during market turmoil, Celularity is expected to outperform it. At this point, Celularity has a negative expected return of -0.16%. Please make sure to confirm Celularity's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Celularity performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Celularity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
If you would invest 3.47 in Celularity on October 19, 2025 and sell it today you would lose (1.85) from holding Celularity or give up 53.31% of portfolio value over 90 days. Celularity is currently producing negative expected returns and takes up 16.0535% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Celularity, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
Assuming the 90 days horizon Celularity is expected to under-perform the market. In addition to that, the company is 23.12 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.
Celularity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celularity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Celularity, and traders can use it to determine the average amount a Celularity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0098
High Returns
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
CELUW
Based on monthly moving average Celularity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celularity by adding Celularity to a well-diversified portfolio.
Celularity Fundamentals Growth
Celularity Stock prices reflect investors' perceptions of the future prospects and financial health of Celularity, and Celularity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celularity Stock performance.
Evaluating Celularity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Celularity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Celularity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Celularity performance evaluation
Checking the ongoing alerts about Celularity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celularity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Celularity generated a negative expected return over the last 90 days
Celularity has some characteristics of a very speculative penny stock
Celularity has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 54.22 M. Net Loss for the year was (57.89 M) with profit before overhead, payroll, taxes, and interest of 20.54 M.
Celularity has accumulated about 38 M in cash with (6.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Celularity's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Celularity's stock performance include:
Analyzing Celularity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celularity's stock is overvalued or undervalued compared to its peers.
Examining Celularity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Celularity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celularity's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Celularity's stock. These opinions can provide insight into Celularity's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Celularity's stock performance is not an exact science, and many factors can impact Celularity's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.